Back to Market Feed

Product Information

GABARONE 100 MG TABLET is a brand (anda) product labeled by INA Pharmaceutics Inc., priced at $8.7889 per EA under NDC 74157001390. Its NADAC has been published 27 times since Feb 18, 2026.

FDA first approved this application on Mar 4, 2024. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

GABARONE 100 MG TABLET

Gabapentin
$8.7889per EA
High Outlier

Strength

100 mg/1

NDC

74157001390

Classification

Brand (ANDA)

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA211313

FDA Approved

3/4/2024

TE Code

AB1

On Market Since

12/23/2024

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABARONE 100 MG TABLET has been published 27 times since Feb 18, 2026, and over the history we have for it it has risen 4.9%. The table below summarizes its recorded NADAC range and movement.

Current price$8.7889 per EA
All-time high$8.7889 (Aug 19, 2026)
All-time low$8.3778 (Feb 18, 2026)
52-week high$8.7889
52-week low$8.3778
Median price$8.7130
Average price$8.6750
Largest weekly change+3.8% (Mar 18, 2026)
Weeks tracked27
Tracking sinceFeb 18, 2026

Price History

1W

0.0%

1M

+0.9%

3M

+0.9%

6M

+4.9%

1Y

N/A

3Y

N/A

5Y

N/A

All

+4.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Gabapentin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

PHENYTEK 200 MG CAPSULE
Brand
00378267001•Mylan Pharmaceuticals Inc.
$1.4033
per EA
PHENYTEK 200 MG CAPSULE
Brand
00378267093•Mylan Pharmaceuticals Inc.
$1.4033
per EA
DILANTIN 30 MG CAPSULE
Brand
58151011801•Viatris Specialty LLC
$1.4985
per EA
DILANTIN 50 MG INFATAB
Brand
00071000724•Pfizer Inc.
$1.5767
per EA
DILANTIN 100 MG CAPSULE
Brand
58151011001•Viatris Specialty LLC
$1.7387
per EA
DILANTIN 100 MG CAPSULE
Brand
58151011088•Viatris Specialty LLC
$1.7387
per EA
DILANTIN 100 MG CAPSULE
Brand
00071036932•Pfizer Inc.
$1.7420
per EA
PHENYTEK 300 MG CAPSULE
Brand
00378375001•Mylan Pharmaceuticals Inc.
$2.0984
per EA
PHENYTEK 300 MG CAPSULE
Brand
00378375093•Mylan Pharmaceuticals Inc.
$2.0984
per EA

Frequently asked questions

What is the NADAC price of GABARONE 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GABARONE 100 MG TABLET, manufactured by INA Pharmaceutics Inc., is $8.7889 per EA (NDC 74157001390), effective Aug 19, 2026.

How has the price of GABARONE 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for GABARONE 100 MG TABLET has risen 4.9%. It has been tracked across 27 weekly CMS publications since Feb 18, 2026.

What are the highest and lowest recorded NADAC prices for GABARONE 100 MG TABLET?

Since Feb 18, 2026, the NADAC for GABARONE 100 MG TABLET has ranged from a low of $8.3778 (Feb 18, 2026) to a high of $8.7889 (Aug 19, 2026), with a median of $8.7130 per EA.

Are there cheaper alternatives to GABARONE 100 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of GABARONE 100 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GABARONE 100 MG TABLET?

GABARONE 100 MG TABLET (NDC 74157001390) is labeled by INA Pharmaceutics Inc., and CMS classifies it as a brand (anda) product.